© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
Liz Parrish, founder of BioViva Sciences discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin.
Peter Voss explains what adaptive, artificial GENERAL intelligence is. He explains the kinds of cognitive feelings these machines need. Finally, he and Dr. Park explore whether machine intelligence can and should be programmed to value and defend itself.